• Investing Insights & Exclusive Offers → Get Our FREE “Market Brief”
    Sign-up for our free weekly newsletter. Get unparalleled investing insights and exclusive Summer Sale discounts on Hedgeye research.

    Disclaimer: By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails. Use of Hedgeye and any other products available through hedgeye.com are subject to our Terms Of Service and Privacy Policy

CLICK HERE TO WATCH THE REPLAY!

Healthcare analyst Tom Tobin and Health Policy analyst Emily Evans reviewed their best stock ideas, major healthcare themes and more.  

WEBCAST REPLAY | Healthcare Q&A: DXCM, DVA, HCA & Labor Trends - chart1

OVERVIEW

The Hedgeye Macro Team has been right on both the deceleration of GDP and the risks associated with the Federal Reserve's response. For Health Care this has meant improving our sensitivity to style factors and incorporating the risks into fundamental views.

For Tenet Healthcare Corp (THC), where we are positive on the fundamentals, the debt factor has been toxic. For DexCom, Inc. (DXCM), the deceleration in growth appears increasingly likely to overwhelm the recent upside and optimism over the long term opportunity. Meanwhile, we continue to see a positive backdrop for utilization, so while the shorts are more likely to work in Quad 4, threading the fundamental needle in the short to intermediate term will be a challenge. Check out the replay of today's Q&A session for more!